GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embecta Corp (FRA:JX7) » Definitions » Short-Term Debt

Embecta (FRA:JX7) Short-Term Debt : €9 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Embecta Short-Term Debt?

Embecta's Short-Term Debt for the quarter that ended in Mar. 2024 was €9 Mil.

Embecta's quarterly Short-Term Debt declined from Sep. 2023 (€9 Mil) to Dec. 2023 (€9 Mil) but then increased from Dec. 2023 (€9 Mil) to Mar. 2024 (€9 Mil).

Embecta's annual Short-Term Debt increased from Sep. 2021 (€0 Mil) to Sep. 2022 (€10 Mil) but then declined from Sep. 2022 (€10 Mil) to Sep. 2023 (€9 Mil).


Embecta Short-Term Debt Historical Data

The historical data trend for Embecta's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embecta Short-Term Debt Chart

Embecta Annual Data
Trend Sep19 Sep20 Sep21 Sep22 Sep23
Short-Term Debt
- - - 9.60 8.90

Embecta Quarterly Data
Sep19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.87 8.77 8.90 8.71 8.74

Embecta Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


Embecta Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Embecta's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Embecta (FRA:JX7) Business Description

Traded in Other Exchanges
Address
300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054
Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

Embecta (FRA:JX7) Headlines

No Headlines